Back to search

University of Sheffield

Exploring striatal neuron and astrocyte dysfunction in amyotrophic lateral sclerosis and frontotemporal dementia using stem cell technology and patch-clamp electrophysiology

Abstract

dc:description.abstract

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are progressive neurodegenerative diseases, part of a spectrum with overlapping pathology, impacting multiple brain regions and non-neuronal cell types beyond the characteristic motor and cortical neuron degeneration. The striatum, an important integrative hub in the brain crucial for functions often impaired in FTD (e.g. behavioural and cognitive regulation, speech and language defects), exhibits dysfunction in FTD/ALS patients. Electrophysiological analysis revealed the first evidence of impaired medium spiny neuron (MSN) function. C9ORF72RE MSNs, harbouring the most common genetic mutation in FTD/ALS, displayed progressive hypoexcitability, abnormal action potential waveforms, impaired function of slow outwardly rectifying potassium (IK) channels and a potential shift in axon initial segment (AIS) positioning. MSN dysfunction may disrupt communication in brain networks, potentially explaining cognitive and behavioural symptoms in FTD/ALS patients. Targeting the discovered IK channel dysfunction and potential AIS changes offers promise for novel pharmaceutical intervention. Astrocytes, essential for neuronal support, contribute to motor neuron death in ALS through a non-cell autonomous mechanism. The loss-of protective-function and gain-of-toxic-feature are likely caused by dysfunctional astrocyte membrane properties. Electrophysiological characterisation of C9ORF72RE astrocytes reveals membrane dysfunction due to connexin 43 (Cx43) dysregulation, mechanism which leads to astrocyte-mediated motor neuron toxicity, orchestrated in part by DPRs, and enhanced by environmental factors. This dysfunction expands to sporadic ALS, FTD and AD patients. Targeting astrocyte connexin dysfunction serves as a potential therapeutic target and biomarker for ALS and other neurodegenerative diseases.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Sheffield
Year dc:date.issued
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Pasniceanu, Iris-Stefania
Advisors dc:contributor.advisor
  • Livesey, Matthew
  • Ferraiuolo, Laura
  • Dos Santos Souza, Cleide
ORCID person:identifier.orcid

Rights

Language dc:language.dcterms_iso639_2
eng

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Pasniceanu, Iris-Stefania. Exploring striatal neuron and astrocyte dysfunction in amyotrophic lateral sclerosis and frontotemporal dementia using stem cell technology and patch-clamp electrophysiology. doctoral thesis, University of Sheffield, 2024.